WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016058116) USE OF CHLOROGENIC ACID IN MANUFACTURING MEDICAMENTS FOR TREATING OLIGODENDROGLIOMA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/058116    International Application No.:    PCT/CN2014/086536
Publication Date: 21.04.2016 International Filing Date: 14.10.2014
IPC:
A61K 31/216 (2006.01), A61P 35/00 (2006.01)
Applicants: SICHUAN JIUZHANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD [CN/CN]; No.10, Second Keyuan South Road, High-Tech District Chengdu, Sichuan 610041 (CN)
Inventors: ZHANG, Jie; (CN).
ZHU, Lina; (CN)
Agent: GAOYUNG INTELLECTUAL PROPERTY AGENCY (GENERAL PARTNERSHIP); The Yiguanmiao Post Office Box A-42, (Ph.D. Entrepreneur Park, No.5 Gaopeng Road), Hi-Tech Zone Chengdu, Sichuan 610041 (CN)
Priority Data:
Title (EN) USE OF CHLOROGENIC ACID IN MANUFACTURING MEDICAMENTS FOR TREATING OLIGODENDROGLIOMA
(FR) UTILISATION DE L'ACIDE CHLOROGÉNIQUE DANS LA PRÉPARATION D'UN MÉDICAMENT INDIQUÉ POUR LE TRAITEMENT DE L'OLIGODENDROGLIOME
(ZH) 绿原酸在制备治疗少突胶质瘤的药物中的用途
Abstract: front page image
(EN)The present invention provides a use of chlorogenic acid in manufacturing medicaments for treating oligodendroglioma. The chlorogenic acid can inhibit oligodendroglioma and the growth of brain tumor stem cells, partially substitute radiotherapy and chemotherapy, and relieve the uncomfortable response of a patient caused by radiotherapy and chemotherapy.
(FR)L'invention concerne l'utilisation de l'acide chlorogénique dans la préparation d'un médicament indiqué pour le traitement de l'oligodendrogliome. L'acide chlorogénique permet d'inhiber à la fois les oligodendrocytes et la production des cellules souches de tumeur du cerveau tout en remplaçant la chimio-radiothérapie partielle, ce qui a pour effet de réduire les effets secondaires provoqués par la chimio-radiothérapie.
(ZH)本发明提供绿原酸在制备治疗少突胶质瘤的药物中的用途。绿原酸能够抑制少突胶质细胞瘤,抑制脑肿瘤干细胞的生长,替代部分放化疗,减轻患者因放化疗引起的不适反应。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)